<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Hussey K</submitter><funding>Gerald Kerkut Charitable Trust</funding><funding>Morris Animal Foundation</funding><pagination>351</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8953681</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(3)</volume><pubmed_abstract>Devil facial tumour disease (DFTD) is a transmissible cancer that has circulated in the Tasmanian devil population for >25 years. Like other contagious cancers in dogs and devils, the way DFTD escapes the immune response of its host is a central question to understanding this disease. DFTD has a low major histocompatibility complex class I (MHC-I) expression due to epigenetic modifications, preventing host immune recognition of mismatched MHC-I molecules by T cells. However, the total MHC-I loss should result in natural killer (NK) cell activation due to the ‘missing self’. Here, we have investigated the expression of the nonclassical MHC-I, Saha-UD as a potential regulatory or suppressive mechanism for DFTD. A monoclonal antibody was generated against the devil Saha-UD that binds recombin</pubmed_abstract><journal>Pathogens (Basel, Switzerland)</journal><pubmed_title>Expression of the Nonclassical MHC Class I, Saha-UD in the Transmissible Cancer Devil Facial Tumour Disease (DFTD).</pubmed_title><pmcid>PMC8953681</pmcid><funding_grant_id>KA Hussey</funding_grant_id><funding_grant_id>D18ZO-104</funding_grant_id><pubmed_authors>Siddle HV</pubmed_authors><pubmed_authors>Skjodt K</pubmed_authors><pubmed_authors>Pye R</pubmed_authors><pubmed_authors>Caldwell A</pubmed_authors><pubmed_authors>Hussey K</pubmed_authors><pubmed_authors>Kreiss A</pubmed_authors><pubmed_authors>Woods GM</pubmed_authors><pubmed_authors>Hamede R</pubmed_authors><pubmed_authors>Gastaldello A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Expression of the Nonclassical MHC Class I, Saha-UD in the Transmissible Cancer Devil Facial Tumour Disease (DFTD).</name><description>Devil facial tumour disease (DFTD) is a transmissible cancer that has circulated in the Tasmanian devil population for >25 years. Like other contagious cancers in dogs and devils, the way DFTD escapes the immune response of its host is a central question to understanding this disease. DFTD has a low major histocompatibility complex class I (MHC-I) expression due to epigenetic modifications, preventing host immune recognition of mismatched MHC-I molecules by T cells. However, the total MHC-I loss should result in natural killer (NK) cell activation due to the ‘missing self’. Here, we have investigated the expression of the nonclassical MHC-I, Saha-UD as a potential regulatory or suppressive mechanism for DFTD. A monoclonal antibody was generated against the devil Saha-UD that binds recombin</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Mar</publication><modification>2026-04-08T17:36:20.179Z</modification><creation>2025-04-06T12:09:08.822Z</creation></dates><accession>S-EPMC8953681</accession><cross_references><pubmed>35335675</pubmed><doi>10.3390/pathogens11030351</doi></cross_references></HashMap>